2006
DOI: 10.1002/lt.20979
|View full text |Cite|
|
Sign up to set email alerts
|

Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
117
0
3

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 168 publications
(120 citation statements)
references
References 26 publications
0
117
0
3
Order By: Relevance
“…Em alguns estudos observa-se que a sobrevida declina rapidamente durante o 1º ano após o transplante e se mantém em um patamar após este período (26) , sendo de 83% ao final de 12 meses, de 72% após o 5º ano e 58% ao final de 10 anos e a sobrevida para os pacientes com escore MELD acima de 36, ao final do 10º ano, foi de 40% (22,23,24,25,26,27) . No Brasil a sobrevida tem sido menor e isto pode ser devido ao expressivo número de doadores com critérios expandidos utilizados (45) .…”
Section: Resultsunclassified
See 1 more Smart Citation
“…Em alguns estudos observa-se que a sobrevida declina rapidamente durante o 1º ano após o transplante e se mantém em um patamar após este período (26) , sendo de 83% ao final de 12 meses, de 72% após o 5º ano e 58% ao final de 10 anos e a sobrevida para os pacientes com escore MELD acima de 36, ao final do 10º ano, foi de 40% (22,23,24,25,26,27) . No Brasil a sobrevida tem sido menor e isto pode ser devido ao expressivo número de doadores com critérios expandidos utilizados (45) .…”
Section: Resultsunclassified
“…Em 2006, o consenso nacional (MESSAGE) para estudos do escore MELD (4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,23,25) não incorporou o sódio sérico ou a presença de ascite ao escore MELD.…”
Section: Introductionunclassified
“…(Bernardi et al 2011). To address this problem, a working group developed a short list of genetic conditions (including familial hyperoxaluria and familial amyloid polyneuropathy) to which exceptions to the MELD system are accepted (Freeman et al 2006) and "unusual metabolic diseases" are included, although few are named as exceptions. A "Share-15" policy was adopted in the US (where 15 % of the organs were to be shared amongst patients with MELD scores below 15) but as programs used these organs for patients on their list with higher MELD scores (Washburn et al 2011), this did not have the desired effect.…”
Section: Discussionmentioning
confidence: 99%
“…Cholangitis and recurrent cholangitis may be the initial symptoms of PSC in 6% and 10% of the cases, respectively (6) . Although there is no evidence of increased mortality or drop out rates of PSC patients in the waiting list for LT due to complications of cholangitis, the adverse impact of recurrent cholangitis in the morbimortality of those patients is a real concern (221,218,222) . In this respect, several Guidelines suggest prioritization of those patients for LT under special circunstances highlighted (218,219) .…”
Section: Recurrent Cholangitismentioning
confidence: 99%